PHARMA JAPAN welcomes JETRO New York’s Shunsuke Tani as a guest columnist. In occasional contributions, Tani will share his perspectives on US pharmaceutical policy, industry developments, and life in America, drawing on his firsthand experience in the US.---Hello from New…
HOME > BUSINESS
BUSINESS
- Ono Launches Opdivo, Making Full-Fledged Entry to Oncology Field
September 3, 2014
- Eisai Books 18.7 Billion Yen in Payments to Medical Institutions in FY2013
September 2, 2014
- Astellas’ FY2013 Funding to Medical Institutions Totals 18.7 Billion Yen
September 2, 2014
- 33.2 Billion Yen Paid to Medical Institutions in FY2013: Daiichi Sankyo
September 2, 2014
- Takeda’s Payments to Health Professionals Down 30% in FY2013
September 2, 2014
- Kyowa Kirin Initiates PIIb Study of Regpara Successor in Japan
September 2, 2014
- Kyowa Kirin Merges Ethics Office into CSR Promotion Dept., Following Improper Involvement of Its Employees in Clinical Study
September 2, 2014
- 10-Year Epidemiology Study Finds No Significant Increase in Bladder Cancer Risk from Actos: Takeda
September 1, 2014
- Novartis Pharma Submits Improvement Plan, Notifies of Over 2,500 Unreported Serious ADRs
September 1, 2014
- Mundipharma Begins PII Trial on Antifolate Pralatrexate in Japan
September 1, 2014
- Daiichi Sankyo Forms Sales Agreement with Kaketsuken for Hepatitis B Vaccine
September 1, 2014
- Fujifilm Starts PI Study of Its Anticancer Agent FF-10501 for Hematological Malignancy in US
September 1, 2014
- Kracie Poised to Re-Enter New Drug Biz with Scabies Treatment
August 29, 2014
- Chugai Provided 17.3 Billion Yen to Healthcare Professionals in 2013, Down 4% from 2012
August 29, 2014
- Sanofi Greater China Head Baschiera to Shepherd Japan Unit
August 29, 2014
- Roche Obtains First Refusal Right for All Chugai’s Products with Partial Amendment to Strategic Alliance Deal
August 29, 2014
- Canaglu to Hit Japan Market on Sept. 3: MTPC, Daiichi Sankyo
August 29, 2014
- Nippon Shinyaku Sets FY2018 Sales Target of 110 Billion Yen, Plans to Focus on Specialty Fields
August 28, 2014
- Novartis Japan Slapped with Warning over Travel Cost Payments for Doctors
August 28, 2014
- MTPC Aims at Over 17% Share for SGLT-2 Inhibitor Canaglu in Japan: Sales Division Head
August 28, 2014
ページ
Japan should fundamentally overhaul its cost-effectiveness assessment (CEA) scheme while putting a hold on CEA-based price adjustments, a new ruling…
Global drug makers are forging ahead with therapies targeting lipoprotein(a), or Lp(a), a promising new approach to reducing cardiovascular risks.…
Japanese Prime Minister Sanae Takaichi said on October 14 that the government will consider the necessary measures for the FY2027…
Eli Lilly’s breast cancer drug Imulrio (imlunestrant) is finally joining Japan’s NHI price list on October 14, nearly 300 days…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…